Abstract
Background
Hypertension (HTN) is a major public health concern, and elevated blood pressure (BP) is a distinct risk factor for all - causes of morbidity and mortality.
Objectives
Considering the growing evidence of yoga interventions in the management of hypertension, the objective of the current randomized controlled study is to assess the effect of OM chanting and Yoga nidra (Relaxation technique) on BP and lipid profile in individuals with HTN.
Materials and methods
Eighty patients with diagnosed HTN were recruited and randomized equally to either the experimental group or the control group. Patients in the experimental group received a combination of OM chanting and Yoga nidra, five days a week for a period of 2 months and patients in the control group continued with their regular conventional medications. BP and lipid profile parameters were assessed at baseline, 30th day and 60th day for both the groups.
Results
After 2 months of intervention, a significant (p < 0.05) reduction in the BP and lipid profile was observed in the intervention group when compared to the control group. The reduction in systolic and diastolic BP and LDL were significantly (p < 0.001) higher in the experimental group. In addition, there is a significant increase in HDL levels in the experimental group. No adverse events were reported during the trial period.
Conclusion
The current study demonstrates the efficacy of Om chanting and Yoga nidra in reducing blood pressure and improving lipid profiles in patients with HTN. These particular yoga interventions could thus be considered a safer form of complementary therapy in the management of HTN, alongside conventional management.
Registration
Clinical trial identifier- CTRI/2020/02/023400.
Keywords: Yoga, Meditation, Yoga nidra, OM chanting, Blood pressure, Lipid profile
1. Introduction
Hypertension is a global public health challenge and elevated blood pressure is one of the leading risk factors for mortality globally [1]. Over 10.4 million deaths have been reported worldwide due to hypertension (HTN) and it is the most preventable and modifiable vascular risk factor for premature morbidity and mortality as well [2,3]. Dyslipidemia is a common metabolic abnormality observed in patients with hypertension. The pathological abnormalities due to dyslipidemia and elevated blood pressure lead to endothelial dysfunction, vascular inflammation, vascular remodeling and atherosclerosis [4]. Reduction in blood pressure, as little as 10 mm Hg in systolic blood pressure (SBP) and 4 mm Hg in diastolic blood pressure (DBP), is reported to reduce the risk of myocardial infarction and stroke by 23% and 30% respectively [5]. Thus, achieving even a smaller reduction in SBP and DBP through non-pharmacological means such as diet, exercise and complementary therapies like yoga would be of greater significance in the management of hypertension alongside conventional management.
Yoga is one of the most popular mind-body therapies widely practiced across the world. Various practices are involved in yoga including physical movements (asanas), controlled respiration (pranayama), relaxation and meditation (dhyana) [6]. The beneficial effects of yoga on various aspects of hypertension are well-documented, especially with pranayama (breathing techniques), meditation and other relaxation techniques in the management of hypertension [[7], [8], [9]].
The American College of Cardiology/American Heart Association (AHA) task force guidelines have emphasized on the importance of lifestyle interventions such as regular exercise and yoga in the effective management of hypertension [10]. Keeping in mind the increase in cardiovascular mortality in low and middle income countries, a community based intervention would be a more effective strategy in the management of hypertension [11]. A simple mind-body intervention like yoga would help patients to practice in the comfort of their homes without much hassles. Most previous studies have focused on asanas and pranayama. There are multiple other simpler practices in yoga that could be performed across all age groups irrespective of the flexibility of a practitioner. However, these components of yoga are least explored scientifically. The objective of the current study is to understand and scientifically explore the effect of integrated relaxation practices of Yoga nidra and Om meditation on blood pressure and lipid profile in patients with elevated blood pressure.
2. Materials and Methods
2.1. Study design
This study was a prospective randomized controlled study conducted on patients with diagnosed HTN. The study was conducted in a private hospital and research center in rural Kerala, South India. BP measurement and lipid profile parameters were evaluated at baseline and after 2 months of intervention.
2.2. Subjects
Patients at Little Flower Medical Research Center, diagnosed with HTN, with a BP range of 130–139/80–89 mmHg, between 25 and 60 years of age were selected. The subjects were under a hypertension diet and taking essential pharmacological therapy. Exclusion criteria were patients with cardio-respiratory diseases, Neuroendocrine diseases, and patients who are practicing yoga or any form of exercise more than 3 days a week. Recruitment was done by giving fliers and were contacted by calling over the telephone. 80 patients who fulfilled the inclusion and exclusion criteria were recruited and randomly assigned to control group (n = 40) and experimental group (n = 40).
2.3. Randomization
For the process of recruitment, 320 patients with HTN were pre-screened. Out of which, 117 patients were screened for eligibility and after applying further inclusion and exclusion criteria, 80 patients who provided informed written consents were randomly allocated to either intervention group (40) or control group (40) through block randomization method. Allocation concealment was done in a sequentially numbered opaque and sealed envelope (SNOSE method), handled by a researcher who was not directly involved in the study. Six patients from the experimental group and nine patients from the control group dropped out of the study.
2.4. Intervention
2.4.1. Om chanting
Patients were trained in ‘Om’ chanting by an experienced yoga trainer. The patients were trained to chant the vowel (O) part of the ‘Om’ followed by the consonant (M) part of the ‘Om’ for 20 s in each chanting. The O part was chanted for a shorter duration (1/3 part)followed by a prolonged M part (2/3 part). They were trained to chant ‘Om’ 3 times per minute for a period of 5 min.
2.4.2. Yoga nidra
After ‘Om’, yoga nidra developed by Swami Satyananda Saraswati, Bihar School of Yoga, India was given to the patients in a supine position for a period of 20 min [12]. All patients were instructed to remain in the lying down position and follow the instructions of the yoga trainer. The practice starts with instructions to relax their entire body and mind as per the instructions provided. Followed by stating a resolve/sankalpa. The sankalpa was given were same for all the subjects and was constant throughout the study period. The subjects were instructed to rotate their consciousness as per the instruction followed by breath awareness. The subjects were instructed to experience the different feelings and emotions and produce a creative visualization of images. They were asked to recollect the Sankalpa at this phase. The subjects were instructed gradually and carefully to return to the normal state.
No active intervention was scheduled for the control group and they continued with their regular medications and usual activities. They were asked to do the follow-up on every 30th and 60th day.
2.5. Outcome measures
BP measurement was carried out using a validated BP monitor (Omron Inc., Japan). After 10 min of rest in a sitting position, BP was estimated in the left arm. A fasting blood sample (5 mL) was collected for assessment of lipid profile markers such as triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) at baseline, on 30th day and 60th day for all the patients.
2.6. Statistical analysis
Descriptive statistics were used to present the baseline characteristics of the data. Normally distributed quantitative data was presented by the mean and standard deviation (SD). Binary and categorical variables were presented using counts and percentages. Between group comparisons of study groups were analyzed using Independent T test or Mann Whitney U test based on normality. The corresponding p-value of less than 0.05 was considered significant for each outcome. All the data entered in Microsoft Excel, and analyzed using SPSS version 20.00.
3. Results
Baseline demographical details of the patients who participated in the present study are shown in Table 1. In the experimental group, the range of age varies from 34 to 60 years with an average of 49.13 ± 8.11 years and in the control group age varies from 25 to 58 years with an average of 43.90 ± 9.24 years. Gender is distributed almost equally in both groups as more than half of the population were females in both groups. BMI distribution shows that our study population is overweight.
Table 1.
Baseline characteristics of the study participants.
Variables | Control group n = 31 |
Experimental group n = 34 |
P value |
---|---|---|---|
Age (yrs, Mean, SD) | 43.90 ± 9.24 | 49.13 ± 8.106 | 0.023∗a |
20-30 (n, %) | 4 (13) | 4 (13) | 0.64# |
30-40 (n, %) | 10 (33.30) | 12 (40) | |
40-50 (n, %) | 15 (50) | 14 (46.70) | |
50-60 (n, %) | 2 (3.30) | 4 (13.30) | |
Gender (n, %) | |||
Male | 14 (45.1) | 15 (44.1) | 0.34# |
Female | 17 (54.8) | 19 (55.8) | |
BMI (kg/m2) | 24.31 ± 1.21 | 25.27 ± 1.38 | 0.95∗ |
∗ Unpaired t test; # chi-square test.
3.1. Blood pressure variables
Within group comparison of study groups shows that in experimental group, compared to initial value, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), mean arterial pressure (MAP), and rate pressure product (RPP) showed a significant reduction on 30th day and it was consistent on 60th day (p < 0.001). There was no statistically significant difference was obtained in control group during the study period. (p > 0.05). The changes in BP variables (SBP, DBP, PP, MAP and RPP) in the experimental group at various time points with a significant improvement (p < 0.001) post-intervention. The improvement in SBP (7.6 ± 3.58 vs 0.88 ± 1.01 mmHg), DBP (4.2 ± 1.52 vs. 1.81 ± 1.99 mmHg), PP (4.6 ± 3.86 vs 2.06 ± 2.12 mmHg), MAP (4.62 ± 1.68 vs 1.29 ± 1.37 mmHg) and RPP (1347.2 ± 459.58 vs. 128.69 ± 153.3 mmHg) for the experimental group at 60th day were significantly higher than control group (Table 2).
Table 2.
Within group comparison of blood pressure parameters among the study groups.
Blood pressure parameters | Experimental group |
Control Group |
||||||
---|---|---|---|---|---|---|---|---|
Initial, Mean ± SD |
30th day, Mean ± SD |
60th day, Mean ± SD |
P Value | Initial, Mean ± SD |
30th day, Mean ± SD |
60th day, Mean ± SD |
P Value | |
SBP(mmHg) | 137.53 ± 3.70 | 134.53 ± 4.66 | 129.93 ± 5.97 | <0.001 | 133.13 ± 3.09 | 132.94 ± 2.83 | 132.88 ± 2.73 | 0.395 |
DBP(mmHg) | 86.13 ± 2.40 | 83.93 ± 2.37 | 81.93 ± 2.43 | <0.001 | 84 ± 4.42 | 83.69 ± 4.04 | 84.69 ± 2.57 | 0.051 |
PP(mmHg) | 52.87 ± 5.77 | 51.33 ± 5.57 | 42.67 ± 3.65 | <0.001 | 48.33 ± 4.55 | 48.13 ± 5.04 | 46.93 ± 3.27 | 0.221 |
MAP(mmHg) | 103.72 ± 2.56 | 100.97 ± 2.81 | 99.23 ± 3.65 | <0.001 | 100.38 ± 3.17 | 100.1 ± 2.71 | 100.75 ± 1.82 | 0.056 |
RPP (bpm-mmHg) | 10446.67 ± 1063.87 | 10012.13 ± 967.53 | 9099.47 ± 887.03 | <0.001 | 9973.75 ± 1293.86 | 9972.5 ± 1232.06 | 9974.81 ± 1188.13 | 0.869 |
Repeated measures ANOVA, P < 0.05 shows statistical significance.
SBP- systolic blood pressure, DBP- diastolic blood pressure, PP-pulse pressure, MAP-mean arterial pressure, RPP-rate pressure product.
3.2. Lipid profile
There was significant improvement (Table 3) in serum lipid markers (TGL, VLDL, LDL, HDL, LDL/HDL and TC/HDL and total cholesterol) as well in the experimental group at the end of 30th day (P < 0.001) and 60th day of intervention (P < 0.001). Difference observed among the experimental group shows that Triglycerides (mg/dl), VLDL (mg/dl), LDL (mg/dl), TC (mg/dl), LDL/HDL, TC/HDL were showed statistically significant decrease on 30th day and on 60th day after receiving Om chanting and yoga nidra (p < 0.05) The HDL (mg/dl), values increased (p < 0.05) significantly during the study period. In the control group, there was no significant differences were observed during the study period. (p > 0.05). The mean difference of TGL (9.33 ± 1.69 vs 0.16 ± 0.63), VLDL (1.87 ± 0.34 vs 0.03 ± 0.13), HDL (4.43 ± 1.72 vs. 0.34 ± 0.87 mg/dl), LDL (9.74 ± 2.30 vs. 0.08 ± 0.26 mg/dl), LDL/HDL (0.64 ± 0.32 vs 0.04 ± 0.09) ratio, TC (6.43 ± 1.75 vs 0.46 ± 0.89) and TC/HDL ratio (0.79 ± 0.4 vs 0.05 ± 0.12) were significantly higher at the end of the 60th day.
Table 3.
Within group comparison of lipid profile among the study groups.
Lipid Profile | Experimental group |
Control Group |
||||||
---|---|---|---|---|---|---|---|---|
Initial, Mean ± SD |
30th day, Mean ± SD |
60th day, Mean ± SD |
P Value | Initial, Mean ± SD |
30th day, Mean ± SD |
60th day, Mean ± SD |
P Value | |
Triglycerides (mg/dl) | 194.17 ± 73.27 | 190.17 ± 73.50 | 184.83 ± 72.67 | <0.001 | 245.16 ± 45.22 | 244.94 ± 45.03 | 245 ± 45 | 0.097 |
VLDL (mg/dl) | 38.8 ± 14.66 | 38.03 ± 14.59 | 37.03 ± 14.59 | <0.001 | 49.03 ± 9.04 | 48.99 ± 9.01 | 49 ± 9 | 0.097 |
HDL (mg/dl) | 40.10 ± 4.58 | 41.23 ± 4.47 | 44.53 ± 3.86 | <0.001 | 35.13 ± 5.75 | 34.91 ± 5.44 | 34.78 ± 5.43 | 0.052 |
LDL (mg/dl) | 164.9 ± 34.421 | 159.90 ± 34.39 | 155.93 ± 34.39 | <0.001 | 166.58 ± 34.34 | 166.61 ± 34.37 | 166.66 ± 34.3 | 0.264 |
TC (mg/dl) | 243.75 ± 35.07 | 239.08 ± 35.41 | 237.32 ± 35.07 | <0.001 | 250.73 ± 35.5 | 250.51 ± 35.5 | 250.44 ± 35.5 | 0.326 |
LDL/HDL | 4.17 ±0.98 | 3.83 ±0.91 | 3.50 ±0.777 | <0.001 | 4.89 ± 1.37 | 4.91 ± 1.35 | 4.92 ± 1.34 | 0.070 |
TC/HDL | 6.13 ± 1.104 | 5.8 ±0.92 | 5.37 ±0.765 | <0.001 | 7.32 ± 1.58 | 7.35 ± 1.56 | 7.37 ± 1.55 | 0.054 |
Repeated measures ANOVA, P < 0.05 shows statistical significance.
TG-triglyceride, TC-total cholesterol, LDL-low density lipoprotein, HDL-high density lipoprotein.
4. Discussion
In the current study, the combination of the two relaxation practices- ‘Om’ chanting and Yoga nidra, showed a statistically significant reduction in SBP, DBP, PP, MAP and, RPP. Similarly, an improvement in the lipid profile was also observed in the intervention group.
The mechanism of action and impact of ‘Om’ chanting on breathing pattern is well-documented. During Om chanting, the breathing rate is slowed down and airway resistance is induced due to the laryngeal contraction to generate the particular sound and vibrational effects, thereby increasing the vagal tone, and resultant physiological relaxation via parasympathetic arousal [13,14]. The changes induced in the respiratory tract impact the ascending vagal activity which would produce a widespread action in critical regulatory centers of the brain. The parasympathetic nervous system (PNS) which gets stimulated by the neurotransmitter GABA from the pre-frontal cortex and insular cortex reduces the hyper activity of the amygdala [15]. Similarly, the changes in breathing patterns will increase the release of hormones such as oxytocin, vasopressin and prolactin, meanwhile reducing the stress markers such as cortisol, via the hypothalamo pituitary adrenal (HPA) axis [16,17]. Mind-body therapies such as yoga have already been shown to improve heart rate variability (HRV) in previous studies, especially slow breathing is reported to influence cardiovagal centers [18].
Previous studies have reported that ‘Om’ sound activates the middle frontal cortex and right supramarginal gyrus which are neural systems associated with the emotion of ‘empathy’ [19] An fMRI study has demonstrated that 15 s loud ‘Om’ chanting stimulates the auricular part of the vagus nerve [20].
Similar to ‘Om’ chanting, Yoga nidra is also an equally effective relaxation practice. Yoga nidra is considered to be a state of relaxation with an altered state of consciousness [21]. The integrated response of Yoga nidra on the hypothalamus results in decreased sympathetic nervous system activity and simultaneously increases the parasympathetic activity as well, by possible activation of the HPA axis [22]. EEG studies showed an initial increase in the beta wave activity during the practice, indicating a calm state of mind being induced in the practitioners [23].
Serum cholesterol levels may be elevated during sympathetic overactivity. Chronic stress may raise cholesterol levels independent of dietary measures [24].
Studies on yoga nidra proved that Yoga nidra effectively reduces stress and anxiety [21].
Previous studies show that pranayama and yogasanas are effective in patients with defective lipid metabolism [25]. This might be due to the parasympathetic stimulatory activity of Om chanting and Yoga nidra [9].
4.1. Strengths and limitations of the study
The major advantage of the study was the intervention, which did not include any physical practices (such as asanas), which makes the current intervention simpler and easier for elderly patients to practice. Having no adverse events being reported by any of the participants is an added advantage. The intervention, in fact, could also be considered as a limitation, because the intervention used in the current study is a combination of two relaxation practices and therefore, the observed beneficial effects could not be attributed to any one single practice in particular.
4.2. Future direction
Future robust studies with adequate sample size would enable to consolidate our findings and help in understanding the beneficial effects of various individual components of yoga. The beneficial effects observed with the two relaxation practices is nevertheless a significant one and could be used as a complementary therapy in the conventional management of hypertension.
5. Conclusion
Combination of the two well-known relaxation practices in yoga has shown to be beneficial in the reducing high BP and lipid profile in patients with hypertension. With no adverse events being reported during the entire duration of the intervention, these specific yogic relaxation practices could be used as a complementary therapy alongside conventional management of hypertension.
Statement of ethics
This study was approved by institutional Ethical board (Ref: EC/26/2018)) from Little flower hospital and research center Angamaly, Kerala, and registered at clinical trial registry (CTRI/2020/02/023400). Written Informed consent was obtained from all the patients before commencement of the intervention.
Funding sources
No external funding sources were involved in any stage of this study.
Author contribution statement
Anjana.K: Conceptualization, Methodology, Formal analysis, Investigation, Resources, Data curation, Validation, Writing - original draft, Visualization. Archana. R: Conceptualization, Methodology, Formal analysis, Validation Writing - review & editing, Supervision. Mukkadan. J.K: Conceptualization, Methodology, Supervision.
Declaration of competing interest
The authors declare no conflict of interest.
Acknowledgements
Ms. Anitha Devi. T.S for all the help provided in statistical analysis. We are also grateful to the subjects who are participated in the study.
Footnotes
Peer review under responsibility of Transdisciplinary University, Bangalore.
References
- 1.Gakidou E., Ashkan A.A., Abajobir A., AbateK H., Abbafati C., Abbas K.A., et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345–1422. doi: 10.1016/S0140-6736(17)32366-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Li A.L., Zhu S., Hu Z.H., Peng Q., Fang X., Zhang Y.Y. The distribution and epidemic characteristics of cerebrovascular disease in followed-up hypertension patients. Sci Rep. 2021;11(1):1–8. doi: 10.1038/s41598-021-88127-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Saiz L.C., Gorricho J., Garjón J., Celaya M.C., Erviti J., Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2020;(9) doi: 10.1002/14651858.cd010315.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Petrie J.R., Guzik T.J., Touyz R.M. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–584. doi: 10.1016/j.cjca.2017.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Staessen J.A., Wang J.-G., Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358(9290):1305–1315. doi: 10.1016/s0140-6736(01)06411-x. [DOI] [PubMed] [Google Scholar]
- 6.Raveendran A.V., Deshpandae A., Joshi S.R. Therapeutic role of yoga in type 2 diabetes. Endocrinol Metab. 2018;33(3):307–317. doi: 10.3803/EnM.2018.33.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wu Y., Johnson B.T., Acabchuk R.L., Chen S., Lewis H.K., Livingston J., et al. Yoga as antihypertensive lifestyle therapy: a systematic review and meta-analysis. Mayo Clin Proc. February 2019 doi: 10.1016/j.mayocp.2018.09.023. Published online. [DOI] [PubMed] [Google Scholar]
- 8.Rajagopalan A., Krishna A., Mukkadan J.K. Abstracts from the international science symposium on HIV and infectious diseases (ISSHID 2019): proceedings. BMC Proc. 2020;14(S7) doi: 10.1186/s12919-020-00190-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rajagopalan A., Krishna A., Mukkadan J.K. Effect of Om chanting and Yoga Nidra on depression anxiety stress, sleep quality and autonomic functions of hypertensive subjects – a randomized controlled trial. J Basic Clin Physiol Pharmacol. 2022 doi: 10.1515/jbcpp-2022-0122. 0(0) [DOI] [PubMed] [Google Scholar]
- 10.Carey R.M., Whelton P.K. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018;168(5):351–358. doi: 10.7326/m17-3203. [DOI] [PubMed] [Google Scholar]
- 11.Jafar T.H., Gandhi M., de Silva H.A., Jehan I., Naheed A., Finkelstein E.A., et al. A community-based intervention for managing hypertension in rural South Asia. N Engl J Med. 2020;382(8):717–726. doi: 10.1056/NEJMoa1911965. [DOI] [PubMed] [Google Scholar]
- 12.Swami Satyananda Saraswati . Yoga Publications Trust; 2003. Yoga nidra. [Google Scholar]
- 13.Harne B.P., Hiwale A.S. EEG spectral analysis on OM mantra meditation: a pilot study. Appl Psychophysiol Biofeedback. 2018;43(2):123–129. doi: 10.1007/s10484-018-9391-7. [DOI] [PubMed] [Google Scholar]
- 14.Dallman M.F., Hellhammer D. Regulation of the hypothalamo-pituitaryadrenal axis, chronic stress, and energy: the role of brain networks. Handb Stress Sci: Biol Psychol Health. 2011:11–36. [Google Scholar]
- 15.Rao N.P., Varambally S., Gangadhar B.N. Yoga school of thought and psychiatry: therapeutic potential. Indian J Psychiatr. 2013;55(Suppl 2):S145. doi: 10.4103/0019-5545.105510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bhagat O.L., Kharya C., Jaryal A., Deepak K.K. Acute effects on cardiovascular oscillations during controlled slow yogic breathing. Indian J Med Res. 2017;145(4):503. doi: 10.4103/ijmr.IJMR_830_15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zou L., Sasaki J.E., Wei G.X., Huang T., Yeung A.S., Neto O.B., et al. Effects of mind–body exercises (Tai Chi/Yoga) on heart rate variability parameters and perceived stress: a systematic review with meta-analysis of randomized controlled trials. J Clin Med. 2018;7(11):404. doi: 10.3390/jcm7110404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hiwale Anil, Harne Bhavna. Survey on Om meditation: its effects on the human body and Om meditation as a tool for stress management. 2019. [DOI]
- 19.Kumar U., Guleria A., Khetrapal C.L. Neuro-cognitive aspects of “OM” sound/syllable perception: a functional neuroimaging study. Cognit Emot. 2015;29(3):432–441. doi: 10.1080/02699931.2014.917609. [DOI] [PubMed] [Google Scholar]
- 20.Kalyani B.G., Venkatasubramanian G., Arasappa R., Rao N.P., Kalmady S.V., Behere R.V., et al. Neurohemodynamic correlates of ‘OM’chanting: a pilot functional magnetic resonance imaging study. Int J Yoga. 2011;4(1):3. doi: 10.4103/0973-6131.78171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Pandi-Perumal S.R., Spence D.W., Srivastava N., Kanchibhotla D., Kumar K., Sharma G.S., et al. The origin and clinical relevance of yoga nidra. Sleep Vigil. 2022;6(1):61–84. doi: 10.1007/s41782-022-00202-7. Epub 2022 Apr 23. PMID: 35496325; PMCID: PMC9033521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dol K.S. Effects of a yoga nidra on the life stress and self-esteem in university students. Compl Ther Clin Pract. 2019;35:232–236. doi: 10.1016/j.ctcp.2019.03.004. [DOI] [PubMed] [Google Scholar]
- 23.Kumar K., Joshi B. NISCAIR Online Periodicals Repository; 2009. Study on the effect of Pranakarshan pranayama and Yoga nidra on alpha EEG & GSR; pp. 453–454. [Google Scholar]
- 24.Cooper M.J., Aygen M.M. A relaxation technique in the management of hypercholesterolemia. J Hum Stress. 1979 Dec;5(4):24–27. doi: 10.1080/0097840x.1979.10545991. PMID: 392003. [DOI] [PubMed] [Google Scholar]
- 25.Prasad Kalepu, Sunita M., Raju P.s, Reddy M., Sahay B.K., Murthy Kolluri. Impact of pranayama and yoga on lipid profile in normal healthy volunteers. J Exerc Physiol Online. 2006 Feb;9:1–6. ISBN: 1097-9751. [Google Scholar]